Anavex Life Sciences Corp.

Anavex Life Sciences Corp. - PE Ratioverified

AVXL

Price:

$2.73

Market Cap:

$252.99M

Operating as a clinical-stage biopharmaceutical entity, Anavex Life Sciences Corp. specializes in developing therapeutic drug candidates for various central nervous system (CNS) conditions. Its leading compound, ANAVEX 2-73, is currently in advanced development, undergoing Phase III clinical evaluation for both Alzheimer's disease and pediatric Rett syndrome. This same drug is also in Phase II trials for Parkinson's disease and is being explored in preclinical studies for a wider range of disorders, including epilepsy, infantile spasms, Fragile X syndrome, Angelman syndrome, multiple sclerosis, and tuberous sclerosis complex. Another significant drug candidate, ANAVEX 3-71, has progressed to...[Read more]

Industry

Biotechnology

IPO Date

2006-08-02

Stock Exchange

NASDAQ

Ticker

AVXL

The PE Ratio as of June 2026 (TTM) for Anavex Life Sciences Corp. (AVXL) is -5.93

According to Anavex Life Sciences Corp.’s latest financial reports and current stock price. The company's current PE Ratio is -5.93. This represents a change of -63.55% compared to the average of -16.27 of the last 4 quarters.

Anavex Life Sciences Corp. (AVXL) Historical PE Ratio (quarterly & annually)

How has AVXL PE Ratio performed in the past?

The mean historical PE Ratio of Anavex Life Sciences Corp. over the last ten years is -13.20. The current -5.93 PE Ratio has changed 4.39% with respect to the historical average. Over the past ten years (40 quarters), AVXL's PE Ratio was at its highest in in the December 2018 quarter at -2.44. The PE Ratio was at its lowest in in the June 2021 quarter at -40.82.

Quarterly (TTM)
Annual

Average

-13.20

Median

-10.92

Minimum

-33.24

Maximum

-5.85

Anavex Life Sciences Corp. (AVXL) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Anavex Life Sciences Corp. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 228.75%

Maximum Annual PE Ratio = -5.85

Minimum Annual Increase = -49.93%

Minimum Annual PE Ratio = -33.24

Quarterly (TTM)
Annual
YearPE RatioChange
2025-16.4850.89%
2024-10.920.06%
2023-10.92-34.42%
2022-16.65-49.93%
2021-33.24228.75%
2020-10.1172.78%
2019-5.85-11.54%
2018-6.62-47.27%
2017-12.5545.15%
2016-8.64-0.39%

Anavex Life Sciences Corp. (AVXL) Average PE Ratio

How has AVXL PE Ratio performed in the past?

The current PE Ratio of Anavex Life Sciences Corp. (AVXL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-12.77

5-year avg

-17.64

10-year avg

-13.20

Anavex Life Sciences Corp. (AVXL) PE Ratio vs. Peers

How is AVXL’s PE Ratio compared to its peers?

Anavex Life Sciences Corp.’s PE Ratio is greater than Erasca, Inc. (-14.70), greater than MeiraGTx Holdings plc (-7.65), less than MoonLake Immunotherapeutics (-4.95), less than Arvinas, Inc. (-2.35), greater than MBX Biosciences, Inc. Common Stock (-19.56), less than Astria Therapeutics, Inc. (-5.88), greater than CytomX Therapeutics, Inc. (-8.17), less than Valneva SE (-2.84), less than REGENXBIO Inc. (-1.39), greater than Absci Corporation (-8.93),

Build a custom stock screener for Anavex Life Sciences Corp. (AVXL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Anavex Life Sciences Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Anavex Life Sciences Corp. (AVXL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Anavex Life Sciences Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Anavex Life Sciences Corp.'s PE Ratio?

How is the PE Ratio calculated for Anavex Life Sciences Corp. (AVXL)?

What is the highest PE Ratio for Anavex Life Sciences Corp. (AVXL)?

What is the 3-year average PE Ratio for Anavex Life Sciences Corp. (AVXL)?

What is the 5-year average PE Ratio for Anavex Life Sciences Corp. (AVXL)?

How does the current PE Ratio for Anavex Life Sciences Corp. (AVXL) compare to its historical average?